BMP2 and occult macular dystrophy: Utilizing the protein synthesis inhibitor cycloheximide (CHX), we found that OMD silence markedly shortened the half‐life of BMP2 (Figure 5L,M), while there was no effect of BMP2 silence on the half‐life of OMD (Figure 5N,O).